2015, Cancer and Medicare - Cardiovascular Update

Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation

Circulation: Cardiovascular Quality & Outcomes

MARCH 5, 2024

In 2020, patients had higher odds of initiating LAAO use than in 2015 (0.52 Patient characteristics, measured 365 days before the first LAAO or OAC use date, were compared using logistic regression.RESULTS:There were 30 058 LAAO recipients (mean age, 77.74 years; female, 42.1%) and 792 600 OAC initiators (mean age, 78.48; female, 53.3%).

Atrial Fibrillation

Atrial Fibrillation Cancer Medicaid Medicare

Abstract 129: Endovascular Therapy in Cerebral Venous Thrombosis: Nationwide Insights and Implications for Mortality

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We examined the demographic and clinical correlates of EVT use in CVT and assessed its impact on patient outcomes utilizing a national database.MethodsWe identified CVT cases from 2015 to 2020 in the National Inpatient Sample, with EVT as the primary exposure. 0.48, p=0.001), CNS cancer (OR: 0.24, 95% CI: 0.06‐0.93,

Thrombosis

Thrombosis Cancer Inpatient Hospital

Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation

Abstract 129: Endovascular Therapy in Cerebral Venous Thrombosis: Nationwide Insights and Implications for Mortality

Stay Connected